#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Thomas Tillett Email
CEO & President . MBF Therapeutics
,
LocationPrimary Email
How to contact Thomas Tillett
Join and see Thomas's contact info for free!Phone
Current Roles
Employees:
20Revenue:
$3.1MAbout
MBF Therapeutics is a life science company developing and commercializing proprietary checkpoint inhibitor immunotherapy technology for cancer and infectious diseases in both animal and human health. T-cell activation precisely targets selected antigens associated with cancer cells or infectious pathogens while preventing T-cell exhaustion, thus, yielding a durable cell-mediated immunity. MBF Therapeutics has in-licensed checkpoint inhibitor technology from several sources. In addition, MBF Therapeutics has discovered novel proprietary immunomodulating technology. These combined with a proprietary nonviral delivery system (CaptaVaxâ„¢), in-licensed from the Southwest Research Institute, provides MBF Therapeutics with a powerful platform technology from which multiple innovative products can be developed for veterinary medicine and human health where cellular antigens are well defined.MBF Therapeutics Address
null, null
United States